Thirty-five-year-old Rekha Sharma, a resident of Nehru Place, leaves for work early in the morning for Noida, masked up and ...

The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.

If over-the-counter antihistamines aren’t effective for you, your doctor may recommend H2 blockers, steroids, biologics, or ...

While inhalers and nasal sprays with corticosteroids are often prescribed for asthma and allergies, experts warn that ...

Atricure, Inc. (($ATRC)) announced an update on their ongoing clinical study. Study Overview: The HEAL-IST IDE Trial, officially titled ‘Hybrid ...

Clinical remission rates were over 85% for both TREMFYA® maintenance doses at 96 weeks in both the Phase 3 GRAVITI and GALAXI studies TREMFYA® is the only ...